Catalyst Wire Dossier Catalyst Wire Dossier

Nouryant

istradefylline · Kyowa Kirin Holdings B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nouryant, covering 2022-01-19 to 2022-01-19. Get the full timeline:

Most recent: EMA Refused: Nouryant (Istradefylline) — Kyowa Kirin Holdings B.V.

See pricing